Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Miyarisan Pharmaceutical Co. Ltd.
DescriptionTablet containing a strain of Clostridium butyricum
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationDiarrhea (infectious)
Indication DetailsTreat and prevent antibiotic-associated diarrhea (AAD); Treat Clostridium difficile-associated disease
Regulatory Designation
PartnerOsel Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today